Filing Details

Accession Number:
0001171843-16-011941
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-08-25 17:00:17
Reporting Period:
2016-08-23
Filing Date:
2016-08-25
Accepted Time:
2016-08-25 17:00:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
722830 Immunomedics Inc IMMU In Vitro & In Vivo Diagnostic Substances (2835) 611009366
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1247904 E Mary Paetzold C/O Immunomedics, Inc.
300 The American Road
Morris Plains NJ 07950
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-08-23 15,000 $1.96 82,474 No 4 M Direct
Common Stock Disposition 2016-08-23 15,000 $2.98 67,474 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, Par Value $0.01 Per Share Stock Options (right to buy) Disposition 2016-08-23 15,000 $0.00 15,000 $1.96
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-08-24 No 4 M Direct
Footnotes
  1. The price in column 4 is a weighted average price. The prices actually received by the reporting person in this transaction range from $2.92 to $3.03.
  2. The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported.
  3. The stock options were granted pursuant to the Immunomedics, Inc. 2002 Stock Option Plan and vested over four years at a rate of 25% per year.